Adjunct to diet & exercise to improve glycemic control in patients w/ type 2 DM as monotherapy, or in combination w/ metformin, sulphonylurea, or PPARγ agonist (ie, thiazolidinedione) as initial therapy, or combination w/ metformin & sulphonylurea, or metformin & PPARγ agonist (ie, thiazolidinedione), when single agent alone or dual therapy, w/ diet & exercise, does not provide adequate glycemic control. Adjunct to diet & exercise to improve glycemic control in combination w/ insulin (w/ or w/o metformin).